Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Jiaoda Onlly CoSHSE:600530 -3.92%39 Gross Margin % is 30.48% as of Mar. 2026, which is 30% below its 10-year median of 43.46. GuruFocus rates SHSE:600530 with a GF Score™ of 39/100 and a GF Value™ of ¥2.95 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 941 Drug Manufacturers companies, Shanghai Jiaoda Onlly Co ranks worse than 80.45% on this metric.
SHSE:600530's Gross Margin % is ranked worse than 80.45% of 941
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs SHSE:600530: 30.27
Shanghai Jiaoda Onlly Co had a gross margin of 30.48% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Shanghai Jiaoda Onlly Co was -9.90% per year.
Shanghai Jiaoda Onlly Co (SHSE:600530) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Shanghai Jiaoda Onlly Co had a gross margin of 30.48% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Shanghai Jiaoda Onlly Co Gross Margin % Related Terms
Shanghai Jiaoda Onlly Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:600530 vs ZTS, UTHR: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Jiaoda Onlly Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Jiaoda Onlly Co Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Jiaoda Onlly Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai Jiaoda Onlly Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Shanghai Jiaoda Onlly Co (SHSE:600530) has a Gross Margin % of 30.48% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai Jiaoda Onlly Co and its competitors. This is 30% below median its historical median of 43.46. Over the past decade, Shanghai Jiaoda Onlly Co's Gross Margin % has ranged from 22.48 to 61.92. According to the industry distribution chart, Shanghai Jiaoda Onlly Co ranks #757 out of 941 companies in the Drug Manufacturers industry, placing it in the top 80.4%.
Is Shanghai Jiaoda Onlly Co's Gross Margin % too high?
Shanghai Jiaoda Onlly Co's current Gross Margin % of 30.48% is 30% below median its 10-year median of 43.46. Over the past 10 years, this metric has ranged from a low of 22.48 to a high of 61.92. The Drug Manufacturers industry median Gross Margin % is 48.54. Shanghai Jiaoda Onlly Co's value of 30.48% is 37.2% below this industry median. Based on the distribution chart, Shanghai Jiaoda Onlly Co ranks #757 out of 941 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shanghai Jiaoda Onlly Co has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Jiaoda Onlly Co's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shanghai Jiaoda Onlly Co ranks #757 out of 941 companies for Gross Margin %. This places Shanghai Jiaoda Onlly Co in the lower half of its industry. The industry median Gross Margin % is 48.54. Shanghai Jiaoda Onlly Co's value of 30.48% is 37.2% below this benchmark. Historically, Shanghai Jiaoda Onlly Co's own Gross Margin % has ranged from 22.48 to 61.92 over the past decade. While the company's 10-year median is 43.46 vs. the industry median of 48.54, Shanghai Jiaoda Onlly Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 941 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Jiaoda Onlly Co's current Gross Margin % of 30.48% is 37.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Shanghai Jiaoda Onlly Co and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Jiaoda Onlly Co's current Gross Margin % is 30.48%, which is 30% below median its own 10-year median of 43.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Jiaoda Onlly Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Jiaoda Onlly Co (SHSE:600530) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.95, compared to a current price of ¥4.66 — trading 58% above its estimated fair value. The current Gross Margin % is 30.48%, which is 30% below median its 10-year median of 43.46 and 37.2% below the Drug Manufacturers industry median of 48.54. Shanghai Jiaoda Onlly Co's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Shanghai Jiaoda Onlly Co (SHSE:600530), the current Gross Margin % is 30.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Jiaoda Onlly Co (SHSE:600530) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Jiaoda Onlly Co stock appears to be overvalued.
The current stock price of ¥4.66 is trading 58% above its estimated GF Value™ of ¥2.95.
GuruFocus considers Shanghai Jiaoda Onlly Co to be Significantly Overvalued.
Key valuation signals for SHSE:600530:
Gross Margin %: 30.48% (30% below median its 10-year median of 43.46)
GF Value™: ¥2.95 vs. price of ¥4.66 (58% above fair value)
Industry Position: 37.2% below the Drug Manufacturers median (#757 of 941)
No single metric tells the full story. See the SHSE:600530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Jiaoda Onlly Co Ltd is engaged in producing and distributing healthcare products. The company is also involved in real estate and financial investment. Its main products are biological products and healthcare products.
39GF Score
Get the complete analysis for SHSE:600530
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600530 has been successfully added to your 
